Because of the vital role TNF family activities in inflammatory responses regulation, antagonists targeting this signaling to reduce chronic inflammation or promote anti-tumor immunity have been developed, and tested or being tested in clinical trials for inflammatory diseases or cancer (9). The gene discussed is TNF; the disease is neoplasm.